A SBIR Phase I contract was awarded to Intra-Cellular Therapies in June, 2016 for $348,094.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Intra-Cellular Therapies in August, 2006 for $729,913.0 USD from the U.S. Department of Defense.
A SBIR Phase I contract was awarded to Intra-Cellular Therapies in November, 2005 for $119,438.0 USD from the U.S. Department of Defense.
A SBIR Phase II contract was awarded to Intra-Cellular Therapies for $2,897,070.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Intra-Cellular Therapies for $349,610.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Intra-Cellular Therapies for $249,377.0 USD from the U.S. Department of Health & Human Services.